DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Miralax (Polyethylene Glycol 3350) - Dysgeusia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Dysgeusia (16)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Miralax (Polyethylene Glycol 3350) where reactions include dysgeusia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Miralax side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient:

Reactions: Dysgeusia

Drug(s) suspected as cause:
Miralax



Possible Miralax side effects in

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient:

Reactions: Dysgeusia, Nausea, Rhinorrhoea

Drug(s) suspected as cause:
Miralax



Possible Miralax side effects in

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient:

Reactions: Dysgeusia, Incorrect Drug Administration Rate, Incorrect Drug Administration Duration, Abnormal Faeces

Drug(s) suspected as cause:
Miralax
    Dosage: unk, tid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-01

Miralax
    Dosage: unk, bid
    Administration route: Oral
    Indication: Medical Observation
    Start date: 2012-07-01



Possible Miralax side effects in

Reported by a consumer/non-health professional from United States on 2012-08-22

Patient:

Reactions: Dysgeusia, Incorrect Drug Administration Duration, Parosmia

Drug(s) suspected as cause:
Miralax
    Dosage: 17 g, qd
    Administration route: Oral
    Indication: Constipation
    Start date: 2009-11-01

Miralax
    Indication: Medical Observation

Miralax
    Indication: Menopause



Possible Miralax side effects in

Reported by a consumer/non-health professional from United States on 2012-08-22

Patient:

Reactions: Dysgeusia, Frequent Bowel Movements, Diarrhoea, Flatulence

Drug(s) suspected as cause:
Miralax
    Dosage: 17 g, qd
    Administration route: Oral
    Indication: Constipation
    Start date: 2012-05-27
    End date: 2012-05-31

Miralax
    Indication: Medical Observation

Other drugs received by patient: Elavil; Align; Elavil; Vitamin D; Calcium (Unspecified) (+) Magnesium (Unspecified); Ascorbic Acid; Effexor; Effexor; Metamucil-2



Possible Miralax side effects in

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient:

Reactions: Dysgeusia

Drug(s) suspected as cause:
Miralax



Possible Miralax side effects in

Reported by a consumer/non-health professional from United States on 2012-08-20

Patient:

Reactions: Dysgeusia, Nausea, Rhinorrhoea

Drug(s) suspected as cause:
Miralax



Possible Miralax side effects in

Reported by a consumer/non-health professional from United States on 2012-08-14

Patient:

Reactions: Dysgeusia

Drug(s) suspected as cause:
Miralax

Other drugs received by patient: Zofran; Protonix; Oxybutynin Chloride



Possible Miralax side effects in

Reported by a consumer/non-health professional from United States on 2012-08-13

Patient:

Reactions: Dysgeusia, Frequent Bowel Movements, Diarrhoea, Flatulence

Drug(s) suspected as cause:
Miralax
    Dosage: 17 g, qd
    Administration route: Oral
    Indication: Constipation
    Start date: 2012-05-27
    End date: 2012-05-31

Miralax
    Indication: Medical Observation

Other drugs received by patient: Effexor; Elavil; Calcium (Unspecified) (+) Magnesium (Unspecified); Ascorbic Acid; Metamucil-2; Effexor; Elavil; Vitamin D; Align



Possible Miralax side effects in

Reported by a consumer/non-health professional from United States on 2012-08-13

Patient:

Reactions: Dysgeusia, Frequent Bowel Movements, Diarrhoea, Flatulence

Drug(s) suspected as cause:
Miralax
    Dosage: 17 g, qd
    Administration route: Oral
    Indication: Constipation
    Start date: 2012-05-27
    End date: 2012-05-31

Miralax
    Indication: Medical Observation

Other drugs received by patient: Elavil; Elavil; Vitamin D; Align; Metamucil-2; Effexor; Ascorbic Acid; Calcium (Unspecified) (+) Magnesium (Unspecified); Effexor



Possible Miralax side effects in

Reported by a consumer/non-health professional from United States on 2012-08-13

Patient:

Reactions: Dysgeusia, Incorrect Drug Administration Duration, Parosmia

Drug(s) suspected as cause:
Miralax
    Indication: Medical Observation

Miralax
    Dosage: 17 g, qd
    Administration route: Oral
    Indication: Constipation
    Start date: 2009-11-01

Miralax
    Indication: Menopause



Possible Miralax side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13

Patient:

Reactions: Dysgeusia, Condition Aggravated

Drug(s) suspected as cause:
Miralax
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Constipation
    Start date: 2012-01-01

Miralax
    Indication: Medical Observation

Miralax
    Indication: Diarrhoea



Possible Miralax side effects in

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient:

Reactions: Dysgeusia

Drug(s) suspected as cause:
Miralax
    Dosage: 8.5 g, prn
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Miralax
    Indication: Medical Observation



Possible Miralax side effects in

Reported by a individual with unspecified qualification from United States on 2012-08-06

Patient:

Reactions: Dysgeusia

Drug(s) suspected as cause:
Miralax



Possible Miralax side effects in

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient:

Reactions: Dysgeusia, Oral Discomfort

Drug(s) suspected as cause:
Miralax



Possible Miralax side effects in

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient:

Reactions: Dysgeusia, Off Label Use, Drug Administered To Patient of Inappropriate AGE

Drug(s) suspected as cause:
Miralax

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017